NYSE International 100
7.777,34
PKT
+38,71
PKT
+0,50
%
Werbung
Analysen zu NYSE International 100-Werten
Datum | Rating | Analyst | |
---|---|---|---|
05.02.25 | Diageo Sell | Deutsche Bank AG | |
05.02.25 | GSK Outperform | Bernstein Research | |
05.02.25 | GSK Neutral | UBS AG | |
05.02.25 | TotalEnergies Outperform | RBC Capital Markets | |
05.02.25 | Santander Buy | Goldman Sachs Group Inc. | |
05.02.25 | Diageo Sell | Goldman Sachs Group Inc. | |
05.02.25 | Deutsche Bank Buy | Goldman Sachs Group Inc. | |
05.02.25 | AXA Buy | Deutsche Bank AG | |
05.02.25 | Allianz Buy | Deutsche Bank AG | |
05.02.25 | Diageo Buy | UBS AG | |
05.02.25 | TotalEnergies Buy | UBS AG | |
03.03.25 | Vodafone Group Neutral | JP Morgan Chase & Co. | |
05.02.25 | Vodafone Group Neutral | JP Morgan Chase & Co. | |
05.02.25 | TotalEnergies Neutral | Goldman Sachs Group Inc. | |
05.02.25 | GSK Underweight | JP Morgan Chase & Co. | |
05.02.25 | Santander Buy | UBS AG | |
05.02.25 | Unilever Outperform | Bernstein Research | |
05.02.25 | Santander Neutral | JP Morgan Chase & Co. | |
05.02.25 | BBVA Outperform | RBC Capital Markets | |
04.02.25 | Vodafone Group Buy | Deutsche Bank AG | |
04.02.25 | AXA Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
04.02.25 | Diageo Sector Perform | RBC Capital Markets | |
04.02.25 | Diageo Neutral | JP Morgan Chase & Co. | |
04.02.25 | Diageo Buy | UBS AG | |
04.02.25 | Vodafone Group Neutral | UBS AG | |
04.02.25 | Diageo Sell | Goldman Sachs Group Inc. | |
04.02.25 | UBS Buy | Goldman Sachs Group Inc. | |
04.02.25 | Vodafone Group Neutral | Goldman Sachs Group Inc. | |
04.02.25 | SAP Add | Baader Bank | |
04.02.25 | UBS Hold | Deutsche Bank AG | |
04.02.25 | UBS Overweight | JP Morgan Chase & Co. | |
04.02.25 | Novartis Buy | Deutsche Bank AG | |
04.02.25 | UBS Outperform | RBC Capital Markets | |
04.02.25 | UBS Buy | Goldman Sachs Group Inc. | |
04.02.25 | Mercedes-Benz Group (ex Daimler) Neutral | Goldman Sachs Group Inc. | |
03.02.25 | Mercedes-Benz Group (ex Daimler) Market-Perform | Bernstein Research | |
03.02.25 | Diageo Neutral | JP Morgan Chase & Co. | |
03.02.25 | Philips Neutral | JP Morgan Chase & Co. | |
03.02.25 | Diageo Buy | Jefferies & Company Inc. | |
03.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. |